SUBSCRIBE
SUBSCRIBE
News   Business

GlaxoSmithKline Signs $2.2 Billion Vaccine Deal with Brazil

September 28, 2009 | 
1 min read
Bookmark and Share

Reuters -- GlaxoSmithKline Plc sealed a 1.5 billion euro ($2.2 billion) deal with Brazil guaranteeing sales of its pneumococcal vaccine for 10 years, the company said on Monday.
Alliances
GlaxoSmithKline
MORE ON THIS TOPIC
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
BMS, Catalent Further Whittle Workforces
February 23, 2026
 · 
57 min read
 · 
BioSpace Editorial Staff
Insights
Redefining Obesity Treatment Beyond GLP-1 Limits
February 19, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Piggy bank rocket launcher with smoke trail on blue background. Savings growth concept. 3D Rendering, 3D Illustration
Alzheimer’s disease
Korsana Joins Alzheimer’s Amyloid Arena With $150M Debut, Next-Gen Antibody
February 18, 2026
 · 
2 min read
 · 
Tristan Manalac